No Data
No Data
Earnings Preview: RIGL to Report Financial Results Post-market on November 07
Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update
Express News | Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for Gavreto® (Pralsetinib)
Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO (Pralsetinib)
Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE
Express News | Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for Tavalisse®
No Data
No Data